U.S. Food Stock News

Johnson & Johnson (JNJ) has opened Q1 2026 with investors focused on how its recent run of earnings ties back to underlying profitability, after reporting Q4 2025 revenue of US$24.6 billion and basic EPS of US$2.10 alongside trailing twelve month EPS of US$11.13 and revenue of US$94.2 billion. Over the last few quarters the company has seen revenue range from US$21.9 billion in Q1 2025 to US$24.6 billion in Q4 2025, while quarterly basic EPS has moved between US$1.41 in Q4 2024 and US$4.57 in...

Cardinal Health released its 2026 Advanced Therapies Report, focusing on how advanced treatments are shifting toward community-based care. The report outlines how providers are rethinking care delivery models to widen patient access outside traditional hospital settings. Findings add new detail to Cardinal Health's role in advanced therapies beyond its previously covered radiopharmaceutical expansions. For investors watching Cardinal Health (NYSE:CAH), the new report lands at a time when...

Replimune Group, Inc. recently received a complete response letter from the FDA rejecting its Biologics License Application for RP1 plus nivolumab in advanced melanoma, despite earlier breakthrough therapy designation and priority review based on the IGNYTE trial data set. The company is publicly challenging what it calls inconsistent FDA processes and shifting review teams, highlighting broader tensions around accelerated approvals for oncology drugs. Next, we’ll examine how the FDA’s...

Earnings slide puts Lindsay (LNN) under closer investor scrutiny Lindsay (LNN) has moved into focus after reporting a year over year decline in both sales and net income for its second quarter and first half of fiscal 2026. The company posted second quarter sales of US$157.72 million and net income of US$12.05 million, compared with US$187.06 million and US$26.58 million a year earlier. This has prompted investors to reassess recent share performance. See our latest analysis for...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Costamare...

If you are wondering whether InterDigital's share price still reflects its underlying value after a strong run, this breakdown is aimed at helping you frame that question clearly. The stock recently closed at US$352.32, with returns of 11.7% over 7 days, 8.0% year to date and 75.2% over 1 year, while the 3 year and 5 year returns are both very large. Recent headlines around InterDigital have focused on its role in software and licensing, along with ongoing interest in how its technology...

Albertsons Companies (ACI) has put another quarter on the board, with Q3 FY 2026 revenue of US$19.1b, basic EPS of US$0.55 and net income of US$293.3m, plus same store sales growth of 2.4%. Over the past few quarters, the company has reported revenue of US$18.8b in Q2 FY 2026 and US$18.8b in Q3 FY 2025, rising to US$19.1b in the latest quarter. Basic EPS over the same periods was US$0.30 and US$0.69 respectively, before reaching US$0.55 in Q3 FY 2026. These figures set the scene for investors...

Riley Exploration Permian, Inc. recently presented at the Water Tower Research Insights Conference on April 14, 2026, offering investors and analysts fresh commentary on its operations and outlook. This conference appearance gives the company a platform to explain its infrastructure plans in New Mexico and ERCOT power initiatives directly to the market. We’ll now consider how this conference presentation, and any additional detail on New Mexico infrastructure and ERCOT power projects, might...

The Schall Law Firm has opened a securities law investigation into Simply Good Foods (NasdaqCM:SMPL). The probe centers on whether the company misled investors or omitted material information before cutting guidance and recording an impairment. This follows earlier attention on the company’s weak earnings, impaired outlook, and share price decline. Simply Good Foods, known for its branded nutritional snacks and meal replacement products, now faces legal scrutiny in addition to its recent...

Over the last 7 days, the United States market has risen by 4.4%, contributing to a remarkable 32% increase over the past year, with earnings forecasted to grow by 16% annually. In this thriving environment, identifying small-cap stocks that are potentially undervalued and exhibit insider buying can offer intriguing opportunities for investors seeking to capitalize on current market conditions.

Over the last week, the United States market has seen a 4.4% increase, contributing to an impressive 32% rise over the past year, with earnings expected to grow by 16% annually. In such a thriving environment, identifying stocks that are potentially undervalued can offer investors opportunities for growth by focusing on companies with strong fundamentals and attractive valuations relative to their peers.

The United States market has experienced a notable upswing, climbing 4.4% in the last week and showing a robust 32% increase over the past year, with earnings forecasted to grow by 16% annually. In this thriving environment, identifying growth companies with high insider ownership can be particularly appealing as they often signal confidence from those closest to the business and potential alignment with shareholder interests.

The market has climbed 4.4% in the last 7 days and is up 32% over the past year, with earnings forecasted to grow by 16% annually. Though the term 'penny stock' might sound like a relic of past trading days, these smaller or newer companies can still offer significant opportunities when they have solid financials. We've identified three penny stocks that combine balance sheet strength with potential for outsized gains, giving investors a chance to uncover hidden value in quality companies.

Over the last 7 days, the United States market has risen by 4.4%, contributing to a remarkable 32% increase over the past year, with earnings expected to grow by 16% annually. In this thriving environment, identifying stocks that combine solid fundamentals with growth potential can uncover promising opportunities for investors seeking undiscovered gems.

Over the last 7 days, the United States market has risen by 4.4%, contributing to a remarkable 32% increase over the past year, with earnings forecasted to grow by 16% annually. In this robust market environment, dividend stocks with yields of at least 3% can offer investors a combination of income and potential capital appreciation, making them an attractive option for those seeking steady returns amidst growth opportunities.

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

If you are trying to figure out whether Fabrinet's share price reflects its real worth, this is the place to start. The stock last closed at US$681.68, with returns of 22.2% over 7 days, 35.8% over 30 days, 42.2% year to date, 261.6% over 1 year, 603.2% over 3 years, and a very large gain over 5 years. Recent coverage of Fabrinet has focused on its role in high performance optical and electronic manufacturing, as customers look for partners that can handle complex, high value hardware. This...

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...

For investors considering whether Borr Drilling at around US$5.70 offers further upside or if expectations are already reflected in the price, a useful starting point is understanding what the current market price implies about value. The stock has seen mixed recent returns, with about a 4.5% decline over the last 7 days, a 12.6% gain over 30 days, and a 42.9% gain year to date. The 1 year return of 203.2% contrasts with a 3 year return reflecting a 19.1% decline and a 5 year return of...

Quest Diagnostics is expanding its drug screening capabilities to meet tighter global testing regulations. The company is rolling out oral fluid and fingerprint-based workplace testing as part of a broader service-focused offering. This shift targets growth opportunities in the global drug screening market beyond routine diagnostics. Quest Diagnostics, NYSE:DGX, is leaning into drug screening as regulators worldwide push for more rigorous and flexible testing options. With a current share...

If you are wondering whether Simpson Manufacturing is priced fairly or if the shares are getting ahead of themselves, the current setup makes valuation the key question. The stock last closed at US$177.89, with returns of 6.8% over 7 days, 8.0% year to date, 19.4% over 1 year, 63.9% over 3 years, and 76.6% over 5 years that many investors will want to put into context. Recent coverage of the company has focused on its position in the capital goods space and how investors are reassessing...

If you are wondering whether Mirion Technologies at around US$19.76 is offering value or stretching expectations, the recent share performance gives you some useful clues before looking at the valuation numbers. The stock has returned 3.6% over the last 7 days and 5.7% over the last 30 days, while the year to date return of a 17.1% decline contrasts with a 41.8% return over the past year and a 134.4% return over 3 years. Over the past year, investors have watched Mirion closely as it has...

Mama's Creations, Inc. has reported past full-year results for the period ended January 31, 2026, with sales of US$171.71 million and net income of US$5.29 million, alongside the upcoming May 1, 2026 appointment of veteran food industry executive Fred Halvin to its Board of Directors. The combination of double-digit top- and bottom-line growth and the addition of a seasoned M&A leader strengthens the company’s operational and governance profile. We’ll now examine how this strong full-year...

Gold.com (NYSE:GOLD) has acquired Sunshine Minting, Inc., expanding directly into minting and refining. The company has created a new Minting & Refining Division and appointed Jamie Meadows as its CEO. This move marks a shift in Gold.com's operational footprint beyond its existing business lines. For investors watching Gold.com at a share price of $44.51, this acquisition comes after substantial long term share price moves, including a 28.0% return year to date and a 202.8% return over five...